Artículos por temáticas

The progression of cognitive deterioration and regional cerebral blood flow patterns in Alzheimer's disease: a longitudinal SPECT study

Hanyu H, Sato T, Hirao K, Kanetaka H, Iwamoto T, Koizumi K.

J Neurol Sci. 2010 Mar 15;290(1-2):96-101. doi: 10.1016/j.jns.2009.10.022. Epub 2009 Nov 20.

Alzheimer's disease: more than amyloid

Chew SH, Meighan Smith Tomic M, Cheung AT.

Clin Hemorheol Microcirc. 2010;46(1):69-73. doi: 10.3233/CH-2010-1356.

Development and validation of the Memory Orientation Screening Test (MOST™): A better screening test for dementia

Clionsky MI, Clionsky E.

Am J Alzheimers Dis Other Demen. 2010 Dec;25(8):650-6. doi: 10.1177/1533317510386216.

Item analysis of ADAS-Cog: effect of baseline cognitive impairment in a clinical AD trial

Sevigny JJ, Peng Y, Liu L, Lines CR.

Am J Alzheimers Dis Other Demen. 2010 Mar;25(2):119-24. doi: 10.1177/1533317509350298.

Non-pharmacologic management of sleep disturbance in Alzheimer's disease

David R, Zeitzer J, Friedman L, Noda A, O'Hara R, Robert P, Yesavage JA.

J Nutr Health Aging. 2010 Mar;14(3):203-6. doi: 10.1007/s12603-010-0050-9.

[Self-reference effect and episodic memory in normal aging and Alzheimer's disease: myth or reality?]

Lalanne J, Grolleau P, Piolino P.

Psychol Neuropsychiatr Vieil. 2010 Dec;8(4):277-94. doi: 10.1684/pnv.2010.0231.

Translational research in genomics of Alzheimer's disease: a review of current practice and future perspectives

Mihaescu R, Detmar SB, Cornel MC, van der Flier WM, Heutink P, Hol EM, Rikkert MG, van Duijn CM, Janssens AC.

J Alzheimers Dis. 2010;20(4):967-80. doi: 10.3233/JAD-2010-1410.

Evaluation of dementia rating scales in Parkinson's disease dementia

Harvey PD, Ferris SH, Cummings JL, Wesnes KA, Hsu C, Lane RM, Tekin S.

Am J Alzheimers Dis Other Demen. 2010 Mar;25(2):142-8. doi: 10.1177/1533317509333904. Epub 2009 Apr 9.

Optical coherence tomography of the retina: applications in neurology

Jindahra P, Hedges TR, Mendoza-Santiesteban CE, Plant GT.

Curr Opin Neurol. 2010 Feb;23(1):16-23. doi: 10.1097/WCO.0b013e328334e99b.

Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease

Frisardi V, Solfrizzi V, Seripa D, Capurso C, Santamato A, Sancarlo D, Vendemiale G, Pilotto A, Panza F.

Ageing Res Rev. 2010 Oct;9(4):399-417. doi: 10.1016/j.arr.2010.04.007. Epub 2010 May 2.

Neuroimaging through the course of Alzheimer's disease

Smith CD.

J Alzheimers Dis. 2010;19(1):273-90. doi: 10.3233/JAD-2010-1217.

Tau in Alzheimer disease and related tauopathies

Iqbal K, Liu F, Gong CX, Grundke-Iqbal I.

Curr Alzheimer Res. 2010 Dec;7(8):656-64. doi: 10.2174/156720510793611592.

The clinical use of structural MRI in Alzheimer disease

Frisoni GB, Fox NC, Jack CR Jr, Scheltens P, Thompson PM.

Nat Rev Neurol. 2010 Feb;6(2):67-77. doi: 10.1038/nrneurol.2009.215.

Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans

Aisen PS, Petersen RC, Donohue MC, Gamst A, Raman R, Thomas RG, Walter S, Trojanowski JQ, Shaw LM, Beckett LA, Jack CR Jr, Jagust W, Toga AW, Saykin AJ, Morris JC, Green RC, Weiner MW; Alzheimer's Dis

Alzheimers Dement. 2010 May;6(3):239-46. doi: 10.1016/j.jalz.2010.03.006.

Anesthetics and Alzheimer's disease. Editorial

Mandal PK, Fodale V.

J Alzheimers Dis. 2010;22 Suppl 3:135-6. doi: 10.3233/JAD-2010-101300.